comprehensive -WSS

comprehensive

author：fashion 2025-10-01 23:58:41 - browse：87

Five people put coins in a box containing coins and cash on stage — coverage from STAT — Adobe

In the United States, health care costs are so out of control that medical crowdfunding has become commonplace. The idea is simple: turn your social network into a financial safety net to cover the cost of expensive treatments or long illnesses. Millions of Americans have started crowdfunding campaigns for medical bills, and tens of millions have donated to them, mostly through the undisputed sector leader, GoFundMe.

Nora Kenworthy, a nursing and health studies professor at the University of Washington, Bothell, has spent years studying the world of crowdfunding for health care — along with the way it ends up amplifying the inequities that already dictate who goes into medical debt.

In her new book, “Crowded Out: The True Costs of Crowdfunding Healthcare,” which will be released on Tuesday, she looks at what she calls the “toxicities” that drive medical crowdfunding campaigns. STAT spoke with Kenworthy about those issues, as well as the difficult moral decisions potential donors face when deciding whether to contribute. The following interview is condensed and edited for clarity.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： FDA approves Eli Lilly ulcerative colitis treatment Omvoh

WSS

Eisai exec who led development of Alzheimer’s drug to retire

ACA's risk program benefits Blue Cross Blue Shield insurers

Tulsa Race Massacre survivors and attorneys respond to dismissal of lawsuit

The pink breast cancer awareness ribbon needs a redesign

CDC recommends rationing of RSV shot due to shortages

Biden targets hefty hospital 'facility fees' that often surprise patients

focus

comprehensive

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

hotspot

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Readout Newsletter: What happened with Sarepta's Duchenne data

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Accuser who called Kevin Spacey 'vile sexual predator' admits he joked about incident

DIEP, the 'gold standard' of breast reconstruction, is under threat

Medtronic CEO on promising devices for diabetes, hypertension

The high cost of giving birth even with insurance

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

Affirmative action in medical school literally saved lives

The aspartame in Diet Coke probably isn’t giving you cancer

Wikipedia

FDA has safety concerns on CRISPR

Biden’s NIH nominee is languishing in Congress

Readout Newsletter: What happened with Sarepta's Duchenne data

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

FDA approves Eli Lilly ulcerative colitis treatment Omvoh

WHO may add ‘noma' to its list of neglected tropical diseases

knowledge

leisure time

focus

focus